1. Impact of NR1I2, adenosine triphosphate–binding cassette transporters genetic polymorphisms on the pharmacokinetics of ginsenoside compound K in healthy Chinese volunteers
   Luping Zhou et al, 2019, Journal of Ginseng Research CrossRef
2. The Role of CYP3A in Health and Disease
   Lyubov S. Klyushova et al, 2022, Biomedicines CrossRef
3. Two curcumin analogs inhibited the function and protein expression of breast cancer resistance protein: in vitro and in vivo studies
   Chung-Ping Yu et al, 2023, Xenobiotica CrossRef
4. Xenobiotic Nuclear Receptors Pregnane X Receptor and Constitutive Androstane Receptor Regulate Antiretroviral Drug Efflux Transporters at the Blood-Testis Barrier
   Sana-Kay Whyte-Allman et al, 2017, Journal of Pharmacology and Experimental Therapeutics CrossRef
5. Xiaoaiping injection enhances paclitaxel efficacy in ovarian cancer via pregnane X receptor and its downstream molecules
   Xiang-Qi Zhang et al, 2020, Journal of Ethnopharmacology CrossRef
6. Nuclear receptors and drug metabolism for the personalization of cancer therapy
   Erika Cecchin et al, 2016, Expert Opinion on Drug Metabolism & Toxicology CrossRef
7. Protein arginine methyltransferase 1 may be involved in pregnane x receptor-activated overexpression of multidrug resistance 1 gene during acquired multidrug resistant
   Tingting Li et al, 2016, Oncotarget CrossRef
8. Transcription factor-mediated regulation of the BCRP/ABCG2efflux transporter: a review across tissues and species
   Ludwik Gorczyca et al, 2020, Expert Opinion on Drug Metabolism & Toxicology CrossRef
9. Time above threshold plasma concentrations as pharmacokinetic parameter in the comparison of oral and intravenous docetaxel treatment of breast cancer tumors
   Maarten van Eijk et al, 2023, Anti-Cancer Drugs CrossRef
10. Associations between Pregnane X Receptor and Breast Cancer Growth and Progression
    Bradley A. Creamer et al, 2020, Cells CrossRef
11. Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancer
    Enrico Garattini et al, 2106, Oncotarget CrossRef
12. Pregnane X receptors regulate CYP2C8 and P‐glycoprotein to impact on the resistance of NSCLC cells to Taxol
    Yan Chen et al, 2016, Cancer Medicine CrossRef
13. Regulation of hepatic P-gp expression and activity by genistein in rats
    M. Semeniuk et al, 2020, Archives of Toxicology CrossRef
14. Pregnane X Receptor, Constitutive Androstane Receptor and Hepatocyte Nuclear Factors as Emerging Players in Cancer Precision Medicine
    Elena De Mattia et al, 2016, Pharmacogenomics CrossRef
15. Pregnane X Receptor and Cancer: Context-Specificity is Key
    Satyanarayana R. Pondugula et al, 2016, Nuclear Receptor Research CrossRef
16. Advances in drug resistance of osteosarcoma caused by pregnane X receptor
    Kunhong Mao et al, 2024, Drug Metabolism Reviews CrossRef
17. Breast cancer and DDT: putative interactions, associated gene alterations, and molecular pathways
    Vijayashree Priyadharsini Jayaseelan et al, 2021, Environmental Science and Pollution Research CrossRef
18. The Interface between Cell Signaling Pathways and Pregnane X Receptor
    Robert S. Rogers et al, 2021, Cells CrossRef
19. Natural medicinal compounds target signal transduction pathways to overcome ABC drug efflux transporter-mediated multidrug resistance in cancer
    Pradhapsingh Bharathiraja et al, 2023, Drug Resistance Updates CrossRef